Random amplified polymorphic DNA (RAPD) markers were used to construct a partial linkage map in a recombinant inbred population derived from the common bean (Phaseolus vulgaris L.) cross BAC 6 × HT 7719 for studying the genetics of disease resistance in common bean. The linkage map spanned 545 cM and included 75 of 84 markers used in this study. The population of 128 recombinant inbred lines was evaluated for resistance to common bacterial blight, foliar resistance to web blight [WB; Thanatephorus cucumeris (Frank) Donk], and resistance to rust [Uromyces appendiculatus var. appendiculatus (Pers.:Pers) Unger]. Common bacterial blight [CBB; Xanthomonas campestris pv. phaseoli (Smith) Dye] resistance was evaluated for CBB strain Epif-IV in later-developed trifoliolate leaves and for CBB strain EK-11 in seeds, first trifoliolate leaves, later-developed trifoliolate leaves, and pods. In addition, lines were rated for plant uprightness and branch density. Two to six markers accounted for 14% to 34% of the phenotypic variation for each trait. Significant marker locustrait associations were found for 14 mapped loci and 7 of the 9 unmapped markers. The distribution of detected QTL appeared to be nonrandom with most significant markers associated with more than one trait or closely linked to markers significantly associated with variation for a different trait. One marker, BC4091250, was significantly associated with WB resistance, resistance for CBB strain Epif-IV in later-developed trifoliolate leaves, and resistance for CBB strain EK-11 in first trifoliolate leaves, later-developed trifoliolate leaves, and pods. A rust resistance gene was mapped in an interval 14.6 cM from RAPD marker H191050 and 12.5 cM from marker AJ16250.
Dry bean (Phaseolus vulgaris L.) production is limited by bean rust [Uromyces appendiculatus (Pers.) Unger var. appendiculatus]. An effective control strategy for this disease is to breed cultivars with durable resistance. Information on the inheritance, genetic relationships, and mapping of genes with molecular markers for specific resistance (SR), adult plant resistance (APR), and abaxial leaf pubescence (ALP) is needed to pyramid the desired genes for durable resistance. ALP was found to be associated previously with APR in Andean germplasm. The objective here was to identify and map RAPD markers for the genes controlling SR, APR, and ALP and to examine their relationships. Five rust pathotypes were inoculated on the unifoliate leaves of 68 recombinant inbred (RI) lines derived from `PC-50' (presence of SR, APR, and ALP) × XAN-159 (absence of SR, APR, and ALP). SR was determined by a single major gene (Ur-9) to the five rust pathotypes with no detection of recombinants. The fourth trifoliolate leaves were inoculated with one pathotype (A88T1-4b). A single major gene Ur-12 controlled APR to that pathotype. The Ur-9 gene (SR) was independent of and epistatic to the Ur-12 gene (APR). Because of the low number of APR lines in the RI population resulting from the elimination of RI lines with SR, an F2 population was developed from a cross of two homozygous RI lines selected for unifoliate susceptibility to pathotype A88T1-4b and for resistance and susceptibility of the fourth trifoliolate leaves to tag RAPD markers linked to the Ur-12 gene (APR). The single major gene Pu-a determinated ALP and was not linked to Ur-9 (SR) and Ur-12 (ALP). The gene Ur-9 (SR) was linked to RAPD marker J13-1100 at 5 cM and was not assigned to any linkage group or other markers. The gene Pu-a (ALP) was mapped at 20.2 cM from 116.500 and 3.9 cM from marker G3.1150 in linkage group 3. The Ur-12 gene (APR) was mapped at 34.6 cM from marker O13.1350 in linkage group 4b. This is the first report of mapping a gene for APR in common bean.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.